Immunotherapy can boost Kras therapy in pancreatic cancer
Add immunotherapy to a new type of inhibitor that is directed to multiple forms of the genetic mutation that causes… Read More »Immunotherapy can boost Kras therapy in pancreatic cancer
Add immunotherapy to a new type of inhibitor that is directed to multiple forms of the genetic mutation that causes… Read More »Immunotherapy can boost Kras therapy in pancreatic cancer
Duke-NUS Medical School scientists have discovered why some pancreatic and colorectal cancers[1] do not respond to Wnt inhibitors, a promising… Read More »Scientists discover key resistance mechanism to Wnt inhibitors in pancreatic and colorectal cancers
Featured Sponsor Store Link Sample Product UK Artful Impressions Premiere Etsy Store Researchers at the University of Michigan Rogel Cancer… Read More »A new study shows that, in mice, the metabolite uridine can feed pancreatic cancer cells when glucose availability is low